Annual EBITDA
-$10.65 M
+$57.63 M+84.40%
December 31, 2024
Summary
- As of March 10, 2025, HCAT annual EBITDA is -$10.65 million, with the most recent change of +$57.63 million (+84.40%) on December 31, 2024.
- During the last 3 years, HCAT annual EBITDA has risen by +$95.47 million (+89.96%).
- HCAT annual EBITDA is now at all-time high.
Performance
HCAT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.48 M
-$3.39 M-373.68%
December 31, 2024
Summary
- As of March 10, 2025, HCAT quarterly EBITDA is -$2.48 million, with the most recent change of -$3.39 million (-373.68%) on December 31, 2024.
- Over the past year, HCAT quarterly EBITDA has stayed the same.
- HCAT quarterly EBITDA is now -373.68% below its all-time high of $908.00 thousand, reached on September 30, 2024.
Performance
HCAT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.65 M
+$15.55 M+59.35%
December 31, 2024
Summary
- As of March 10, 2025, HCAT TTM EBITDA is -$10.65 million, with the most recent change of +$15.55 million (+59.35%) on December 31, 2024.
- Over the past year, HCAT TTM EBITDA has stayed the same.
- HCAT TTM EBITDA is now -5.14% below its all-time high of -$10.13 million, reached on March 31, 2018.
Performance
HCAT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HCAT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +84.4% | 0.0% | 0.0% |
| 3 y3 years | +90.0% | 0.0% | 0.0% |
| 5 y5 years | +77.5% | +80.9% | +77.5% |
HCAT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.0% | -373.7% | +92.8% | at high | +90.0% |
| 5 y | 5-year | at high | +90.0% | -373.7% | +92.8% | at high | +90.0% |
| alltime | all time | at high | +90.0% | -373.7% | +92.8% | -5.1% | +90.0% |
Health Catalyst EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$10.65 M(-84.4%) | -$2.48 M(-373.7%) | -$10.65 M(-59.4%) |
| Sep 2024 | - | $908.00 K(-195.1%) | -$26.21 M(-29.3%) |
| Jun 2024 | - | -$955.00 K(-88.2%) | -$37.07 M(-33.9%) |
| Mar 2024 | - | -$8.12 M(-55.0%) | -$56.09 M(-17.9%) |
| Dec 2023 | -$68.28 M(-25.5%) | -$18.04 M(+81.1%) | -$68.28 M(-12.5%) |
| Sep 2023 | - | -$9.96 M(-50.1%) | -$78.05 M(-21.5%) |
| Jun 2023 | - | -$19.97 M(-1.7%) | -$99.48 M(+0.0%) |
| Mar 2023 | - | -$20.31 M(-27.0%) | -$99.46 M(+8.5%) |
| Dec 2022 | -$91.71 M(-13.6%) | -$27.81 M(-11.4%) | -$91.71 M(-6.8%) |
| Sep 2022 | - | -$31.40 M(+57.4%) | -$98.42 M(-0.2%) |
| Jun 2022 | - | -$19.95 M(+58.9%) | -$98.58 M(-3.7%) |
| Mar 2022 | - | -$12.55 M(-63.6%) | -$102.35 M(-3.6%) |
| Dec 2021 | -$106.12 M | -$34.52 M(+9.4%) | -$106.12 M(+1.3%) |
| Sep 2021 | - | -$31.56 M(+33.0%) | -$104.77 M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$23.72 M(+45.3%) | -$91.34 M(+3.8%) |
| Mar 2021 | - | -$16.32 M(-50.8%) | -$87.99 M(+2.4%) |
| Dec 2020 | -$85.91 M(+81.5%) | -$33.17 M(+83.0%) | -$85.91 M(+30.7%) |
| Sep 2020 | - | -$18.12 M(-11.1%) | -$65.75 M(+1.1%) |
| Jun 2020 | - | -$20.38 M(+43.0%) | -$65.06 M(+26.5%) |
| Mar 2020 | - | -$14.24 M(+9.5%) | -$51.42 M(+8.7%) |
| Dec 2019 | -$47.32 M(-10.2%) | -$13.01 M(-25.4%) | -$47.32 M(+4.1%) |
| Sep 2019 | - | -$17.43 M(+159.0%) | -$45.47 M(+7.7%) |
| Jun 2019 | - | -$6.73 M(-33.7%) | -$42.22 M(-19.8%) |
| Mar 2019 | - | -$10.15 M(-9.0%) | -$52.66 M(+0.0%) |
| Dec 2018 | -$52.68 M(+32.9%) | -$11.16 M(-21.3%) | -$52.64 M(+26.9%) |
| Sep 2018 | - | -$14.18 M(-17.4%) | -$41.48 M(+51.9%) |
| Jun 2018 | - | -$17.17 M(+69.5%) | -$27.30 M(+169.5%) |
| Mar 2018 | - | -$10.13 M | -$10.13 M |
| Dec 2017 | -$39.65 M | - | - |
FAQ
- What is Health Catalyst annual EBITDA?
- What is the all time high annual EBITDA for Health Catalyst?
- What is Health Catalyst annual EBITDA year-on-year change?
- What is Health Catalyst quarterly EBITDA?
- What is the all time high quarterly EBITDA for Health Catalyst?
- What is Health Catalyst quarterly EBITDA year-on-year change?
- What is Health Catalyst TTM EBITDA?
- What is the all time high TTM EBITDA for Health Catalyst?
- What is Health Catalyst TTM EBITDA year-on-year change?
What is Health Catalyst annual EBITDA?
The current annual EBITDA of HCAT is -$10.65 M
What is the all time high annual EBITDA for Health Catalyst?
Health Catalyst all-time high annual EBITDA is -$10.65 M
What is Health Catalyst annual EBITDA year-on-year change?
Over the past year, HCAT annual EBITDA has changed by +$57.63 M (+84.40%)
What is Health Catalyst quarterly EBITDA?
The current quarterly EBITDA of HCAT is -$2.48 M
What is the all time high quarterly EBITDA for Health Catalyst?
Health Catalyst all-time high quarterly EBITDA is $908.00 K
What is Health Catalyst quarterly EBITDA year-on-year change?
Over the past year, HCAT quarterly EBITDA has changed by $0.00 (0.00%)
What is Health Catalyst TTM EBITDA?
The current TTM EBITDA of HCAT is -$10.65 M
What is the all time high TTM EBITDA for Health Catalyst?
Health Catalyst all-time high TTM EBITDA is -$10.13 M
What is Health Catalyst TTM EBITDA year-on-year change?
Over the past year, HCAT TTM EBITDA has changed by $0.00 (0.00%)